Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 1;13:868915. doi: 10.3389/fimmu.2022.868915

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Milo, Staun-Ram, Karussis, Karni, Hellmann, Bar-Haim, Miller and The Israeli Neuroimmunology Study Group on COVID-19 Vaccination in Multiple Sclerosis

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

(A) Correlation between IgG after 2^nd vaccine and absolute lymphocyte count in Fingolimod-treated patients (N=29). (B) IgG levels of Fingolimod-treated patients at 3 time-points: ≤3months and 6 months from 2^nd vaccine and ≤3 months from 3^rd vaccine. (C) Mean IgG levels in Fingolimod-treated patients at 3 time-points: ≤3months and 6 months from 2^nd vaccine and ≤3 months from 3^rd vaccine. Dashed horizontal grey line represents minimum seropositive border (log10(50AU/ml), dashed vertical line represent normal lymphocyte count border.